{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:03:16Z","timestamp":1790139796103,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82271266, No. 82071255, No. 81873751"],"award-info":[{"award-number":["No. 82271266, No. 82071255, No. 81873751"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1104900"],"award-info":[{"award-number":["2022YFA1104900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Provincial Clinical Research Center for Neurological Diseases","award":["2020B1111170002"],"award-info":[{"award-number":["2020B1111170002"]}]},{"name":"Guangdong Province International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases","award":["2020A0505020004"],"award-info":[{"award-number":["2020A0505020004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04688-0","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:15:03Z","timestamp":1770891303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An autonomous siRNA delivery system targeting NLRP3: implications in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Lishan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weineng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic Zhentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajing","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"10291","key":"4688_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"10423","key":"4688_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","volume":"403","author":"T Foltynie","year":"2024","unstructured":"Foltynie T, Bruno V, Fox S, Kuhn AA, Lindop F, Lees AJ. Medical, surgical, and physical treatments for Parkinson\u2019s disease. Lancet. 2024;403(10423):305\u201324.","journal-title":"Lancet"},{"issue":"10423","key":"4688_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024;403(10423):293\u2013304.","journal-title":"Lancet"},{"issue":"11","key":"4688_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"4688_CR5","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38(8):1285\u201391.","journal-title":"Neurology"},{"issue":"7","key":"4688_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","volume":"31","author":"CH Williams-Gray","year":"2016","unstructured":"Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR, et al. Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD). Mov Disord. 2016;31(7):995\u20131003.","journal-title":"Mov Disord"},{"issue":"6","key":"4688_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol. 2003;106(6):518\u201326.","journal-title":"Acta Neuropathol"},{"key":"4688_CR8","doi-asserted-by":"crossref","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016;167(6):1469\u20131480 e1412.","DOI":"10.1016\/j.cell.2016.11.018"},{"issue":"9","key":"4688_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1212\/WNL.0000000000001308","volume":"84","author":"Y Hu","year":"2015","unstructured":"Hu Y, Yu SY, Zuo LJ, Cao CJ, Wang F, Chen ZJ, et al. Parkinson disease with REM sleep behavior disorder: features, alpha-synuclein, and inflammation. Neurology. 2015;84(9):888\u201394.","journal-title":"Neurology"},{"issue":"11","key":"4688_CR10","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1080\/15548627.2019.1596481","volume":"15","author":"X Han","year":"2019","unstructured":"Han X, Sun S, Sun Y, Song Q, Zhu J, Song N, et al. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Autophagy. 2019;15(11):1860\u201381.","journal-title":"Autophagy"},{"key":"4688_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102134","volume":"47","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, et al. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson\u2019s disease. Redox Biol. 2021;47:102134.","journal-title":"Redox Biol"},{"issue":"12","key":"4688_CR12","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","volume":"16","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liao Y, Dong Y, Hu H, Yang N, Kong X, et al. Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice. Autophagy. 2020;16(12):2193\u2013205.","journal-title":"Autophagy"},{"key":"4688_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"4688_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee E, Hwang I, Park S, Hong S, Hwang B, Cho Y, et al. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ. 2019;26(2):213\u201328.","journal-title":"Cell Death Differ"},{"issue":"7784","key":"4688_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373.","journal-title":"Nature"},{"issue":"1","key":"4688_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12974-021-02349-y","volume":"18","author":"J Chen","year":"2021","unstructured":"Chen J, Mao K, Yu H, Wen Y, She H, Zhang H, et al. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson\u2019s disease. J Neuroinflammation. 2021;18(1):295.","journal-title":"J Neuroinflammation"},{"key":"4688_CR17","doi-asserted-by":"crossref","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O'Neill LA et al. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. 2018;10(465):eaah4066.","DOI":"10.1126\/scitranslmed.aah4066"},{"key":"4688_CR18","doi-asserted-by":"crossref","unstructured":"Lei H, Len R, Sun Y, Zhang K, Zhao X, Ablat N, Pu X. Neuroprotective Effects of Safflower Flavonoid Extract in 6-Hydroxydopamine-Induced Model of Parkinson's Disease May Be Related to its Anti-Inflammatory Action. Molecules. 2020;25(21):5206.","DOI":"10.3390\/molecules25215206"},{"issue":"1","key":"4688_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12974-023-02759-0","volume":"20","author":"A Grotemeyer","year":"2023","unstructured":"Grotemeyer A, Fischer JF, Koprich JB, Brotchie JM, Blum R, Volkmann J, et al. Inflammasome inhibition protects dopaminergic neurons from alpha-synuclein pathology in a model of progressive Parkinson\u2019s disease. J Neuroinflammation. 2023;20(1):79.","journal-title":"J Neuroinflammation"},{"issue":"21","key":"4688_CR20","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1111\/bph.15972","volume":"180","author":"P Ranasinghe","year":"2023","unstructured":"Ranasinghe P, Addison ML, Dear JW, Webb DJ. Small interfering RNA: discovery, pharmacology and clinical development-an introductory review. Br J Pharmacol. 2023;180(21):2697\u2013720.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4688_CR21","first-page":"187","volume":"85","author":"K Gavrilov","year":"2012","unstructured":"Gavrilov K, Saltzman WM. Therapeutic siRNA: principles, challenges, and strategies. Yale J Biol Med. 2012;85(2):187\u2013200.","journal-title":"Yale J Biol Med"},{"issue":"4","key":"4688_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","volume":"67","author":"N Agrawal","year":"2003","unstructured":"Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev. 2003;67(4):657\u201385.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"11","key":"4688_CR23","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1093\/brain\/awab354","volume":"144","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wu T, Shan Y, Li G, Ni X, Chen X, et al. Therapeutic reversal of Huntington\u2019s disease by in vivo self-assembled siRNAs. Brain. 2021;144(11):3421\u201335.","journal-title":"Brain"},{"issue":"2","key":"4688_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.","journal-title":"J Extracell Vesicles"},{"issue":"42","key":"4688_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405364","volume":"11","author":"W Zhang","year":"2024","unstructured":"Zhang W, Ren J, Ding L, Zheng S, Ma R, Zhang M, et al. Nanotherapeutic approaches of interleukin-3 to clear the alpha-Synuclein pathology in mouse models of Parkinson\u2019s disease. Adv Sci (Weinh). 2024;11(42):e2405364.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"4688_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.it.2022.09.010","volume":"43","author":"G Lawrence","year":"2022","unstructured":"Lawrence G, Holley CL, Schroder K. Parkinson\u2019s disease: connecting mitochondria to inflammasomes. Trends Immunol. 2022;43(11):877\u201385.","journal-title":"Trends Immunol"},{"issue":"7149","key":"4688_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature05901","volume":"448","author":"P Kumar","year":"2007","unstructured":"Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 2007;448(7149):39\u201343.","journal-title":"Nature"},{"issue":"5","key":"4688_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/mt.2010.27","volume":"18","author":"SS Kim","year":"2010","unstructured":"Kim SS, Ye C, Kumar P, Chiu I, Subramanya S, Wu H, et al. Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther. 2010;18(5):993\u20131001.","journal-title":"Mol Ther"},{"issue":"2","key":"4688_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41423-022-00962-2","volume":"20","author":"CG Hsu","year":"2023","unstructured":"Hsu CG, Li W, Sowden M, Chavez CL, Berk BC. Pnpt1 mediates NLRP3 inflammasome activation by MAVS and metabolic reprogramming in macrophages. Cell Mol Immunol. 2023;20(2):131\u201342.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"4688_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/brain\/awae304","volume":"148","author":"Z Li","year":"2025","unstructured":"Li Z, Du X, Yang Y, Zhang L, Chen P, Kan Y, et al. Treatment of neurological pathology and inflammation in Machado-Joseph disease through in vivo self-assembled siRNA. Brain. 2025;148(3):817\u201332.","journal-title":"Brain"},{"key":"4688_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114861","volume":"197","author":"P Khare","year":"2023","unstructured":"Khare P, Edgecomb SX, Hamadani CM, Tanner EEL, D SM. Lipid nanoparticle-mediated drug delivery to the brain. Adv Drug Deliv Rev. 2023;197:114861.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4688_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11095-022-03433-5","volume":"40","author":"A D'Souza","year":"2023","unstructured":"D\u2019Souza A, Nozohouri S, Bleier BS, Amiji MM. CNS delivery of nucleic acid therapeutics: beyond the blood-brain barrier and towards specific cellular targeting. Pharm Res. 2023;40(1):77\u2013105.","journal-title":"Pharm Res"},{"issue":"6","key":"4688_CR33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, et al. Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron. 2012;74(6):1031\u201344.","journal-title":"Neuron"},{"issue":"2","key":"4688_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/stem.3103","volume":"38","author":"TT Wu","year":"2020","unstructured":"Wu TT, Su FJ, Feng YQ, Liu B, Li MY, Liang FY, et al. Mesenchymal stem cells alleviate AQP-4-dependent glymphatic dysfunction and improve brain distribution of antisense oligonucleotides in BACHD mice. Stem Cells. 2020;38(2):218\u201330.","journal-title":"Stem Cells"},{"key":"4688_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","volume":"144","author":"Y Dong","year":"2019","unstructured":"Dong Y, Siegwart DJ, Anderson DG. Strategies, design, and chemistry in siRNA delivery systems. Adv Drug Deliv Rev. 2019;144:133\u201347.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"4688_CR36","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/nar\/gky1239","volume":"47","author":"A Biscans","year":"2019","unstructured":"Biscans A, Coles A, Haraszti R, Echeverria D, Hassler M, Osborn M, et al. Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo. Nucleic Acids Res. 2019;47(3):1082\u201396.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4688_CR37","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X, Liaw WS, Chen CA, Zhou QA. Exosomes horizontal line Nature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano. 2022;16(11):17802\u201346.","journal-title":"ACS Nano"},{"key":"4688_CR38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jconrel.2022.12.027","volume":"353","author":"J Mondal","year":"2023","unstructured":"Mondal J, Pillarisetti S, Junnuthula V, Saha M, Hwang SR, Park IK, et al. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Control Release. 2023;353:1127\u201349.","journal-title":"J Control Release"},{"issue":"7434","key":"4688_CR39","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138.","journal-title":"Nature"},{"issue":"3","key":"4688_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-022-02466-9","volume":"144","author":"E Van Schoor","year":"2022","unstructured":"Van Schoor E, Ospitalieri S, Moonen S, Tome SO, Ronisz A, Ok O, et al. Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex. Acta Neuropathol. 2022;144(3):393\u2013411.","journal-title":"Acta Neuropathol"},{"key":"4688_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbi.2022.11.014","volume":"108","author":"M Kodali","year":"2023","unstructured":"Kodali M, Madhu LN, Reger RL, Milutinovic B, Upadhya R, Gonzalez JJ, et al. Intranasally administered human MSC-derived extracellular vesicles inhibit NLRP3-p38\/MAPK signaling after TBI and prevent chronic brain dysfunction. Brain Behav Immun. 2023;108:118\u201334.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"4688_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen S, Koper MJ, Van Schoor E, Schaeverbeke JM, Vandenberghe R, von Arnim CAF, et al. Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 2023;145(2):175\u201395.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4688_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11481-011-9269-4","volume":"7","author":"JA Hutter-Saunders","year":"2012","unstructured":"Hutter-Saunders JA, Gendelman HE, Mosley RL. Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication. J Neuroimmune Pharmacol. 2012;7(1):279\u201388.","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04688-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04688-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04688-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:23:31Z","timestamp":1773833011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04688-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4688"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04688-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Sun Yat-sen University, Guangzhou, China. The approval number is [SYSU-IACUC-2024-003197].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not appliable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}